Sugammadex-induced bronchospasm: a case report
김세영, 윤민재, 정훈, 김지현,
소속 상세정보
김세영 ( Kim Sae-Young ) - Kyungpook National University School of Medicine Department of Anesthesiology and Pain Medicine
윤민재 ( Yoon Min-Jae ) -
정훈 ( Jung Hoon ) - Kyungpook National University School of Medicine Department of Anesthesiology and Pain Medicine
김지현 ( Kim Ji-Hyun ) - Kyungpook National University School of Medicine Department of Anesthesiology and Pain Medicine
Abstract
Sugammadex has shown faster reversal of steroidal neuromuscular blockade (NMB) than neostigmine, a traditional reversal agent for NMB, even in the intense block phase. This efficiency is possible because of the unique mechanism of action by encapsulating the NMB molecules. Therefore, with the use of sugammadex, we can also expect to avoid direct interactions with the cholinergic system and its subsequent side effects, which are disadvantages of traditional drugs. However, despite these benefits and US Food and Drug Administration (FDA) approval in 2015, rare adverse events associated with sugammadex have been reported. Herein, we report a case of bronchospasm that developed immediately after sugammadex administration.
키워드
Anaphylaxis; Bronchial Spasm; Neuromuscular Blockade
원문 및 링크아웃 정보
등재저널 정보